Free Delivery Over $100
|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Franz-Xaver Reichl , Michael SchwenkPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG Edition: 2nd ed. 2021 Weight: 3.291kg ISBN: 9783030574987ISBN 10: 3030574989 Pages: 1594 Publication Date: 27 September 2021 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Language: English Table of ContentsTests and Methods.- Approaches used.- Paradigms Used in Risk Evaluation.- Risk Assessment and Evaluation.- Risk Management and Risk Communication.- Regulated Areas.- Addendum: Tables and Lists.ReviewsAuthor InformationFranz-Xaver Reichl studied microbiology and medicine in Munich, Germany. He then qualified as a toxicologist/ pharmacologist and works at the Ludwig Maximilians University of Munich (LMU) as a dental-toxicologist at the Dental Clinic and at the Walther-Straub-Institute of Pharmacology and Toxicology at the LMU. His research is mainly related to molecular, cellular, and analytical (dental) toxicology and toxicity. F.X. Reichl consulted health agencies in toxicological risk management and is member of toxicological/pharmacological committees. He is head of the “International Advisory Board for the Biocompatibility/Toxicology of Dental Materials” at the LMU and is “Officer for Biosafety of Bacteria and Viruses” at the LMU Munich. Michael Schwenk studied biochemistry and medicine in Tübingen, Germany, and thereafter specialized in pharmacology, toxicology, and nutritional and environmental medicine. He was appointed professor in Pharmacology and Toxicology in 1987. He worked in xix universities, basic research institutions, pharmaceutical industry, and a state health agency. He created and headed the Regulatory Toxicology Study Group of the German Society of Toxicology, consulted health agencies in toxicological risk management, and was secretary of the IUPAC Division Chemistry and Human Health. His research areas include membrane transport of xenobiotics, drug-biomolecule interactions, drug metabolism, cytotoxicity, phase I clinical studies, human biomonitoring, and risk assessment. Tab Content 6Author Website:Countries AvailableAll regions |
||||
